Abbott Laboratories (ABT)Rep. Thomas H. Kean (NJ07) disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

37 days

Disclosure lag

Traded

Dec 16, 2024

Disclosed

Jan 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 21, 2024Insider · 1 personInsiders: 3 sales (~$18.4M)
2. Dec 11, 2024CongressDisclosed partial sale of ABT — reported range $15,001 - $50,000
3. Dec 16, 2024 · this disclosureCongressDisclosed purchase of ABT — reported range $1,001 - $15,000

What came next

1. Jan 6, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
2. Jan 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
3. Jan 15, 2025Congress · 1 personMembers of Congress: 3 sales
4. Jan 28, 2025InsiderOfficer sold ~$337K of ABT shares in the open market
5. Jan 28, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
6. Jan 29, 2025InsiderOfficer sold ~$16.9M of ABT shares in the open market
7. Jan 29, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
8. Jan 30, 2025FDAFDA device clearance: simpli-COLLECT STI Test
9. Jan 30, 2025Insider · 2 peopleInsiders: 2 sales (~$10.5M)
10. Feb 3, 2025FDARecall: CardioMEMS Heart Failure (HF) System that consist of: -CardioMEMS Hospital System Model CM3100 -CardioMEMS Backend Web Application Model CM4000 -Merlin.net Pat…
11. Feb 5, 2025InsiderCEO sold ~$37.4M of ABT shares in the open market
12. Feb 13, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
13. Feb 14, 2025FDAFDA device clearance: Alinity m Resp-4-Plex
14. Feb 15, 2025FDARecall: Aveir DR Leadless Pacemaker (LP) Ventricular Device REF LSP202V UDI-DI code: 05415067040725 REF LSP112V UDI-DI code: 05415067034472 The Aveir leadless pacemake…
15. Feb 20, 2025FDAFDA device clearance: Alinity h-series System
16. Feb 24, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
17. Mar 3, 2025Insider · 5 peopleInsiders: 5 sales (~$549K)
18. Mar 6, 2025InsiderOfficer sold ~$12.2M of ABT shares in the open market
19. Mar 6, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
20. Mar 7, 2025InsiderOfficer sold ~$27K of ABT shares in the open market

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 82 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Thomas H. Kean (NJ07)

• House Clerk periodic transaction report at Alphabet (GOOGL)Sep 12, 2026
• House Clerk periodic transaction report at Amcor (AMCR)Sep 12, 2026
• House Clerk periodic transaction report at Johnson & Johnson (JNJ)Sep 12, 2026
• House Clerk periodic transaction report at Linde plc (LIN)Sep 12, 2026
• House Clerk periodic transaction report at MasTec (MTZ)Sep 12, 2026

The full history of Rep. Thomas H. Kean (NJ07) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Abbott Laboratories

• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 20, 2026

Everything OQRO holds on this company is on its ABT page.